Starting in June, ClinOne will automatically link an active clinical trial to its online patient-matching website as an integrated solution, eliminating the duplication of costs and administration.
ClinOne's central information source for patients allows patients to quickly and easily search clinical trial options, without the burden of searching institution by institution.
Direct-to-patient matching will be included in ClinOne's clinical trial suite; the company anticipates the cost savings to clinical trial sponsors could be 80-90% of their current recruitment costs.
The ClinOne solution and its suite of products were created to improve clinical trial enrollment, retention and research site compliance.
The company's sole mission is to allow important trial details to be at the fingertips of participating researchers and patients.
Currently, more than 2,600 active clinical trials in 50 countries rely on ClinOne's suite of technologies.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA